Pacemaker and implantable cardioverter defibrillator infections;Infections liées aux pacemakers et défibrillateurs implantables

Medecine et Maladies Infectieuses

Volumn 40, Issue 8, 2010, Pages 429-439

  Camus, C ^a   Donal, E ^a   Bodi, S ^a   Tattevin, P ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Bloodstream infection; Defibrillator; Infective endocarditis; Pacemaker; Staphylococcus sp

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFUROXIME; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTIFICIAL HEART PACEMAKER; BLOODSTREAM INFECTION; DEFIBRILLATOR; DEVICE INFECTION; DEVICE REMOVAL; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; ENDOCARDITIS; HUMAN; INCIDENCE; INFECTION PREVENTION; NONHUMAN; PACEMAKER ELECTRODE; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

DEFIBRILLATORS, IMPLANTABLE; HUMANS; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS;

EID: 77955982299     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2009.11.005     Document Type: Review

References (102)

1. Chua J.D., Wilkoff B.L., Lee I., Juratli N., Longworth D.L., Gordon S.M. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000, 133:604-608.
2. Schwartz I.S., Pervez N. Bacterial endocarditis associated with a permanent transvenous cardiac pacemaker. JAMA 1971, 218(5):736-737.
3. Corman L.C., Levison M.E. Sustained bacteremia and transvenous cardiac pacemakers. JAMA 1975, 233:264-266.
4. Goldberger Z., Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA 2006, 295:809-818.
5. Cabell C.H., Heidenreich P.A., Chu V.H., Moore C.M., Stryjewski M.E., Corey G.R., et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J 2004, 147:582-586.
6. Mond H.G., Irwin M., Morillo C., Ector H. The world survey of cardiac pacing and cardioverter defibrillators: calendar year 2001. Pacing Clin Electrophysiol 2004, 27:955-964.
7. Sohail M.R., Uslan D.Z., Khan A.H., Friedman P.A., Hayes D.L., Wilson W.R., et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007, 49:1851-1859.
8. Baddour L.M., Bettmann M.A., Bolger A.F., Epstein A.E., Ferrieri P., Gerber M.A., et al. Nonvalvular cardiovascular device-related infections. Circulation 2003, 108:2015-2031.
9. Chambers S.T. Diagnosis and management of staphylococcal infections of pacemakers and cardiac defibrillators. Intern Med J 2005, 35(Suppl. 2):S63-S71.
10. Gandelman G., Frishman W.H., Wiese C., Green-Gastwirth V., Hong S., Aronow W.S., et al. Intravascular device infections: epidemiology, diagnosis, and management. Cardiol Rev 2007, 15:13-23.
11. Uslan D.Z., Sohail M.R., St Sauver J.L., Friedman P.A., Hayes D.L., Stoner S.M., et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 2007, 167:669-675.
12. Choo M.H., Holmes D.R., Gersh B.J., Maloney J.D., Merideth J., Pluth J.R., et al. Permanent pacemaker infections: characterization and management. Am J Cardiol 1981, 48:559-564.
13. Chamis A.L., Peterson G.E., Cabell C.H., Corey G.R., Sorrentino R.A., Greenfield R.A., et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001, 104:1029-1033.
14. Catanchin A., Murdock C.J., Athan E. Pacemaker infections: a 10-year experience. Heart Lung Circ 2007, 16:434-439.
15. Selton-Suty C., Doco-Lecompte T., Freisz L., Chometon F., Duhoux F., Blangy H., et al. L'endocardite sur matériel de stimulation intracardiaque. Ann Cardiol Angeiol 2008, 57(2):81-87.
16. Klug D., Wallet F., Lacroix D., Marquié C., Kouakam C., Kacet S., et al. Local symptoms at the site of pacemaker implantation indicate latent systemic infection. Heart 2004, 90:882-886.
17. Von Reyn C.F., Levy B.S., Arbeit R.D., Friedland G., Crumpacker C.S. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med 1981, 94:505-518.
18. Durack D.T., Lukes A.S., Bright D.K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994, 96:200-209.
19. Li J.S., Sexton D.J., Mick N., Nettles R., Fowler V.G., Ryan T., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638.
20. Arber N., Pras E., Copperman Y., Schapiro J.M., Meiner V., Lossos I.S., et al. Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine (Baltimore) 1994, 73:299-305.
21. Klug D., Lacroix D., Savoye C., Goullard L., Grandmougin D., Hennequin J.L., et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 1997, 95:2098-2107.
22. Dumont E., Camus C., Victor F., de Place C., Pavin D., Alonso C., et al. Suspected pacemaker or defibrillator transvenous lead infection. Prospective assessment of a TEE-guided therapeutic strategy. Eur Heart J 2003, 24:1779-1787.
23. Jenkins S.M., Hawkins N.M., Hogg K.J. Pacemaker endocarditis in patients with prosthetic valve replacements: case trilogy and literature review. Pacing Clin Electrophysiol 2007, 30:1279-1283.
24. Massoure P.L., Reuter S., Lafitte S., Laborderie J., Bordachard P., Clementy J., et al. Pacemaker endocarditis: clinical features and management of 60 consecutive cases. Pacing Clin Electrophysiol 2007, 30:12-19.
25. Rundström H., Kennergren C., Andersson R., Alestig K., Hogevik H. Pacemaker endocarditis during 18 years in Göteborg. Scand J Infect Dis 2004, 36:674-679.
26. Sohail M.R., Uslan D.Z., Khan A.H., Friedman P.A., Hayes D.L., Wilson W.R., et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007, 45:166-173.
27. Uslan D.Z., Sohail M.R., Friedman P.A., Hayes D.L., Wilson W.R., Steckelberg J.M., et al. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with Gram negative bacteremia. Clin Infect Dis 2006, 43:731-736.
28. Duval X., Selton-Suty C., Alla F., Salvador-Mazenq M., Bernard Y., Weber M., et al. Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin Infect Dis 2004, 39:68-74.
29. Cacoub P., Leprince P., Nataf P., Hausfater P., Dorent R., Wechsler B., et al. Pacemaker infective endocarditis. Am J Cardiol 1998, 82:480-484.
30. Trappe H.J., Pfitzner P., Klein H., Wenzlaff P. Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years. Br Heart J 1995, 73:20-24.
31. Conklin E.F., Giannelli S., Nealon T.F. Four hundred consecutive patients with permanent transvenous pacemakers. J Thorac Cardiovasc Surg 1975, 69:1-7.
32. Grögler F.M., Frank G., Greven G., Dragojevic D., Oelert H., Leitz K., et al. Complications of permanent transvenous cardiac pacing. J Thorac Cardiovasc Surg 1975, 69:895-904.
33. Frame R., Brodman R.F., Furman S., Andrews C.A., Gross J.N. Surgical removal of infected transvenous pacemaker leads. Pacing Clin Electrophysiol 1993, 16:2343-2348.
34. Kearney R.A., Eisen H.J., Wolf J.E. Nonvalvular infections of the cardiovascular system. Ann Intern Med 1994, 121:219-230.
35. Hill P.E. Complications of permanent transvenous cardiac pacing: a 14-year review of all transvenous pacemakers inserted at one community hospital. Pacing Clin Electrophysiol 1987, 10:564-570.
36. Klug D., Balde M., Pavin D., Hidden-Lucet F., Clementy J., Sadoul N., et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 2007, 116:1349-1355.
37. Morgan G., Ginks W., Siddons H., Leatham A. Septicemia in patients with an endocardial pacemaker. Am J Cardiol 1979, 44:221-224.
38. Harjula A., Järvinen A., Virtanen K.S., Mattila S. Pacemaker infections: treatment with total or partial pacemaker system removal. Thorac Cardiovasc Surg 1985, 33:218-220.
39. del Río A., Anguera I., Miró J.M., Mont L., Fowler V.G., Azqueta M., et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest 2003, 124:1451-1459.
40. Smith P.N., Vidaillet H.J., Hayes J.J., Wethington P.J., Stahl L., Hull M., et al. Infections with nonthoracotomy implantable cardioverter defibrillators: can these be prevented? Endotak Lead Clinical Investigators. Pacing Clin Electrophysiol 1998, 21:42-55.
41. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877-883.
42. Lewis A.B., Hayes D.L., Holmes D.R., Vlietstra R.E., Pluth J.R., Osborn M.J. Update on infections involving permanent pacemakers. Characterization and management. J Thorac Cardiovasc Surg 1985, 89:758-763.
43. Karchmer A.W., Longworth D.L. Infections of intracardiac devices. Infect Dis Clin North Am 2002, 16:477-505.
44. Villamil Cajoto I., Rodríguez Framil M., Van den Eynde Collado A., José Villacián Vicedo M., Canedo Romero C. Permanent transvenous pacemaker infections: an analysis of 59 cases. Eur J Intern Med 2007, 18:484-488.
45. Rettig G., Doenecke P., Sen S., Volkmer I., Bette L. Complications with retained transvenous pacemaker electrodes. Am Heart J 1979, 98:587-594.
46. Marschall J., Hopkins-Broyles D., Jones M., Fraser V.J., Warren D.K. Case-control study of surgical site infections associated with pacemakers and implantable cardioverter-defibrillators. Infect Control Hosp Epidemiol 2007, 28:1299-1304.
47. Mela T., McGovern B.A., Garan H., Vlahakes G.J., Torchiana D.F., Ruskin J., et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter-defibrillator implants. Am J Cardiol 2001, 88:750-753.
48. Klug D., Vaksmann G., Jarwé M., Wallet F., Francart C., Kacet S., et al. Pacemaker lead infection in young patients. Pacing Clin Electrophysiol 2003, 26:1489-1493.
49. Da Costa A., Lelièvre H., Kirkorian G., Célard M., Chevalier P., Vandenesch F., et al. Role of the preaxillary flora in pacemaker infections: a prospective study. Circulation 1998, 97:1791-1795.
50. Wohl B., Peters R.W., Carliner N., Plotnick G., Fisher M. Late unheralded pacemaker pocket infection due to Staphylococcus epidermidis: a new clinical entity. Pacing Clin Electrophysiol 1982, 5:190-195.
51. Camus, Dumont E, De Place C, Arvieux C, Michelet C, Daubert JC, et al. Definite or possible pacemaker-related endocarditis (PME): evaluation of device removal criteria and long-term follow-up. Abstracts of the 41th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 22-2, 2001, Chicago, IL; L-1340:466.
52. Myers T.J., Khan T., Frazier O.H. Infectious complications associated with ventricular assist systems. ASAIO J 2000, 46:S28-36.
53. Klug D., Wallet F., Kacet S., Courcol R.J. Involvement of adherence and adhesion Staphylococcus epidermidis genes in pacemaker lead-associated infections. J Clin Microbiol 2003, 41:3348-3350.
54. Camus C., Leport C., Raffi F., Michelet C., Cartier F., Vilde J.L. Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal. Clin Infect Dis 1993, 17:46-55.
55. Mylonakis E., Calderwood S.B. Infective endocarditis in adults. N Engl J Med 2001, 345:1318-1330.
56. Victor F., De Place C., Camus C., Le Breton H., Leclercq C., Pavin D., et al. Pacemaker lead infection: echocardiographic features, management, and outcome. Heart 1999, 81:82-87.
57. Lauck G. Adherent structures on implanted leads of cardiac pacemaker. Circulation 1994, 4(Suppl. I):70. [Abstract].
58. Lo R., D'Anca M., Cohen T., Kerwin T. Incidence and prognosis of pacemaker lead-associated masses: a study of 1569 transesophageal echocardiograms. J Invasive Cardiol 2006, 18:599-601.
59. Dalal A., Asirvatham S.J., Chandrasekaran K., Seward J.B., Tajik A.J. Intracardiac echocardiography in the detection of pacemaker lead endocarditis. J Am Soc Echocardiogr 2002, 15:1027-1028.
60. Rosenbaum G.S., Calubiran O., Cunha B.A. Haemophilus parainfluenzae bacteremia associated with a pacemaker wire localized by gallium scan. Heart Lung 1990, 19:271-273.
61. Ramackers J.M., Kotzki P.O., Couret I., Messner-Pellenc P., Davy J.M., Rossi M. The use of technetium-99m hexamethylpropylene amine oxime labelled granulocytes with single-photon emission tomography imaging in the detection and follow-up of recurrence of infective endocarditis complicating transvenous endocardial pacemaker. Eur J Nucl Med 1995, 22:1351-1354.
62. Vos F.J., Bleeker-Rovers C.P., van Dijk A.P., Oyen W.J. Detection of pacemaker and lead infection with FDG-PET. Eur J Nucl Med Mol Imaging 2006, 33:1245.
63. Camus C, Moisan A, Victor F, Arvieux C, Devillers A, Michelet C, et al. Assessment of Tc-99m HMPAO labeled granulocytes sac (TcGS) for the diagnosis and management of pacemaker-related endocarditis. Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 24-27, 1998, San Diego, CA; 53-K K-39:512.
64. Zainal Abidin I., Syed Tamin S., Huat Tan L., Chong W.P., Azman W. Pacemaker infection secondary to Burkholderia pseudomallei. Pacing Clin Electrophysiol 2007, 30:1420-1422.
65. van Winkelhoff A.J., Overbeek B.P., Pavicić M.J., van den Bergh J.P., Ernst J.P., de Graaff J. Long-standing bacteremia caused by oral Actinobacillus actinomycetemcomitans in a patient with a pacemaker. Clin Infect Dis 1993, 16:216-218.
66. Nurnberger M., Treadwell T., Lin B., Weintraub A. Pacemaker lead infection and vertebral osteomyelitis presumed due to Cardiobacterium hominis. Clin Infect Dis 1998, 27:890-891.
67. Giannella M., Valerio M., Franco J.A., Marin M., Bouza E., Muñoz P. Pacemaker infection due to Mycobacterium fortuitum: the role of universal 16S rRNA gene PCR and sequencing. Diagn Microbiol Infect Dis 2007, 57:337-339.
68. Siu C.W., Cheng L.C., Woo P.C., Lau C.P., Tse H.F. A patient with relapsing pacemaker infection due to " Gram positive bacilli" Int J Cardiol 2007, 114:E40-E41.
69. Roger P.M., Boissy C., Gari-Toussaint M., Foucher R., Mondain V., Vandenbos F., et al. Medical treatment of a pacemaker endocarditis due to Candida albicans and to Candida glabrata. J Infect 2000, 41:176-178.
70. Joly V., Belmatoug N., Leperre A., Robert J., Jault F., Carbon C., et al. Pacemaker endocarditis due to Candida albicans: case report and review. Clin Infect Dis 1997, 25:1359-1362.
71. Cole W.J., Slater J., Kronzon I., Galler M., Trehan N., Cohen M., et al. Candida albicans-infected transvenous pacemaker wire: detection by two-dimensional echocardiography. Am Heart J 1986, 111:417-418.
72. Izquierdo R., Llorente C., Mayo J., Garcia-Porrua C., Gonzalez-Juanatey C., Gonzalez-Gay M.A. Pacemaker infection due to Aspergillus: report of two cases and literature review. Clin Cardiol 2005, 28:36-38.
73. Moorman J.R., Steenbergen C., Durack D.T. Aspergillus infection of a permanent ventricular pacing lead. Pacing Clin Electrophysiol 1984, 7:361-366.
74. Foo H., Ooi S.Y., Giles R., Jones P. Scedosporium apiospermum pacemaker endocarditis. Int J Cardiol 2009, 131(2):e81-82.
75. Houpikian P., Raoult D. Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine (Baltimore) 2005, 84:162-173.
76. Klug D., Wallet F., Kacet S., Courcol R.J. Detailed bacteriologic tests to identify the origin of transvenous pacing system infections indicate a high prevalence of multiple organisms. Am Heart J 2005, 149:322-328.
77. Yamada M., Takeuchi S., Shiojiri Y., Maruta K., Oki A., Iyano K., et al. Surgical lead-preserving procedures for pacemaker pocket infection. Ann Thorac Surg 2002, 74:1494-1499.
78. Dieter R.A. Preserving infected pacemaker systems. Ann Thorac Surg 2004, 77:1504-1505.
79. Bracke F.A., Meijer A., van Gelder L.M. Pacemaker lead complications: when is extraction appropriate and what can we learn from published data?. Heart 2001, 85:254-259.
80. Byrd C.L., Schwartz S.J., Hedin N.B., Goode L.B., Fearnot N.E., Smith H.J. Intravascular lead extraction using locking stylets and sheaths. Pacing Clin Electrophysiol 1990, 13:1871-1875.
81. Tascini C., Bongiorni M.G., Leonildi A., Giannola G., Soldati E., Arena G., et al. Pacemaker endocarditis with pulmonary cavitary lesion due to Scedosporium prolificans. J Chemother 2006, 18:667-669.
82. Myers M.R., Parsonnet V., Bernstein A.D. Extraction of implanted transvenous pacing leads: a review of a persistent clinical problem. Am Heart J 1991, 121(3 Pt 1):881-888.
83. Byrd C.L., Schwartz S.J., Hedin N. Intravascular techniques for extraction of permanent pacemaker leads. J Thorac Cardiovasc Surg 1991, 101:989-997.
84. Neuzil P., Taborsky M., Rezek Z., Vopalka R., Sediva L., Niederle P., et al. Pacemaker and ICD lead extraction with electrosurgical dissection sheaths and standard transvenous extraction systems: results of a randomized trial. Europace 2007, 9:98-104.
85. Miralles A., Moncada V., Chevez H., Rodriguez R., Granados J., Castells E. Pacemaker endocarditis: approach for lead extraction in endocarditis with large vegetations. Ann Thorac Surg 2001, 72:2130-2132.
86. Meier-Ewert H.K., Gray M.E., John R.M. Endocardial pacemaker or defibrillator leads with infected vegetations: a single-center experience and consequences of transvenous extraction. Am Heart J 2003, 146:339-344.
87. Ruttmann E., Hangler H.B., Kilo J., Höfer D., Müller L.C., Hintringer F., et al. Transvenous pacemaker lead removal is safe and effective even in large vegetations: an analysis of 53 cases of pacemaker lead endocarditis. Pacing Clin Electrophysiol 2006, 29:231-236.
88. Abad C., Manzano J.J., Quintana J., Bolaños J., Manzano J.L. Removal of infected dual chambered transvenous pacemaker and implantation of a new epicardial dual chambered device with cardiopulmonary bypass: experience with seven cases. Pacing Clin Electrophysiol 1995, 18:1272-1275.
89. Smyth E.G., Pallister D. Septicaemia in patients with temporary and permanent endocardial pacemakers. J R Soc Med 1989, 82:396-398.
90. Villamil-Cajoto I., Van den Eynde A., Rodriguez-Framil M., Paramo-de Vega M. Escherichia coli pacemaker-related endocarditis. Clin Microbiol Infect 2006, 12:1241.
91. Loulergue P., Lortholary O., Mainardi J.L., Lecuit M. Hafnia alvei endocarditis following pyelonephritis in a permanent pacemaker carrier. Clin Infect Dis 2007, 44:621.
92. Baddour L.M., Wilson W.R. Infections of prosthetic valves and other cardiovascular devices. Electrophysiologic cardiac devices. Principles and practice of infectious diseases-6th 2005, 1033-1034. Elsevier Churchill Livingstone, Philadelphia. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
93. Cosgrove S., Fowler V. Management of MRSA bacteremia. Clin Infect Dis 2008, 47:S386-S389.
94. Baddour L.M. Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci 2001, 322:209-212. Infectious Diseases Society of America's Emerging Infections Network.
95. O'Nunain S., Perez I., Roelke M., Osswald S., McGovern B.A., Brooks D.R., et al. The treatment of patients with infected implantable cardioverter-defibrillator systems. J Thorac Cardiovasc Surg 1997, 113:121-129.
96. Ruiz M., Anguita M., Castillo J.C., Delgado M., Romo E., Torres F., et al. Pacemaker-related endocarditis: clinical features and treatment. J Heart Valve Dis 2006, 15:122-124.
97. Moukarbel G.V., Tabbarah Z.A., Khoury M.Y. Successful treatment of pacemaker related endocarditis with acute embolic stroke without device removal. J Interv Card Electrophysiol 2003, 9:39-42.
98. Shalev A., Gilad J., Riesenberg K., Borer A., Kobal S., Schlaeffer F., et al. Conservative management of implantable cardioverter defibrillator-related endocarditis due to Bacillus spp. Infection 2007, 35:114-117.
99. Love C.J., Wilkoff B.L., Byrd C.L., Belott P.H., Brinker J.A., Fearnot N.E., et al. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training. Pacing Clin Electrophysiol 2000, 23:544-551.
100. Da Costa A., Kirkorian G., Cucherat M., Delahaye F., Chevalier P., Cerisier A., et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 1998, 97:1796-1801.
101. Danchin N., Duval X., Leport C. Révision de la conférence de consensus de la prophylaxie de l'endocardite infectieuse. Med Mal Infect 2002, 32:562-595.
102. Habib G., Hoen B., Tornos P., et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009, 30(19):2369-2413.